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Abstract 
The regulatory control mechanisms of lipid and fatty acid metabolism were investigated in 
Atlantic salmon. We identified sterol regulatory element binding protein (SREBP) genes in 
salmon and characterised their response, and the response of potential target and other 
regulatory genes including liver X receptor (LXR), to cholesterol and long-chain 
polyunsaturated fatty acids (LC-PUFA) in the salmon established cell line, SHK-1. Two 
cDNAs for SREBPs homologous to mammalian SREBP-1 and SREBP-2 were characterised. 
We identified three groups of genes whose expression responded differently to the 
treatments. One group of genes, including cholesterol biosynthetic genes, showed increased 
expression in response to lipid depletion but supplementary cholesterol or LC-PUFA had no 
further effect. The expression of a second group of genes belonging to fatty acid biosynthetic 
pathways, included fatty acid synthase, Δ6 and Δ5 fatty acyl desaturases, also increased after 
lipid depletion but this was negated by cholesterol or by LC-PUFA supplementation. The 
expression of a third group of genes including acyl-CoA oxidase, HMG-CoA reductase and 
Elovl5 elongase was increased by cholesterol treatment but was not affected by lipid 
depletion or by LC-PUFA. This same pattern of expression was also shown by liver X 
receptor (LXR), indicating that acyl-CoA oxidase, HMG-CoA reductase and Elovl5 are 
possible direct targets of LXR. This suggests that salmon Elovl5 may be regulated differently 
from mammalian Elovl5, which is an indirect target of LXR, responding to LXR-dependent 
increases in SREBP-1. 
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Introduction  
 
Fish, especially oily fish such as Atlantic salmon (Salmo salar), are unique sources in the 
human diet of the omega-3 or n-3 long-chain polyunsaturated fatty acids (LC-PUFA) 
eicosapentaenoate (EPA, 20:5n-3) and docosahexaenoate (DHA, 22:6n-3) [1], that have well-
established beneficial effects in a number of inflammatory and pathological conditions, 
including cardiovascular and neurological diseases [2-4]. Consequently, there is considerable 
interest in lipid and fatty acid homeostasis in fish, particularly the molecular mechanisms of 
endogenous LC-PUFA synthesis. In mammals, the nuclear receptors liver X receptors, LXRs, 
and transcription factors, sterol regulatory element binding proteins, SREBPs, are major 
regulators of lipid metabolism. In mammals, the LXR subfamily consists of two encoded 
genes, LXRα and LXRβ [5] and, similarly, the SREBP subfamily is encoded by two genes, 
SREBF1 and SREBF2 [6]. SREBP-1 and SREBP-2 are major regulators of mammalian fatty 
acid/lipid and cholesterol biosynthetic genes, respectively, including genes of LC-PUFA 
synthesis [7]. In vertebrates LC-PUFA synthesis proceeds by consecutive desaturation and 
elongation steps of the dietary essential precursors linoleic (18:2n-6) and linolenic acids 
(18:3n-3), catalysed by Δ5 and Δ6 fatty acyl desaturases (Fad) and fatty acyl elongase (Elovl) 
enzymes [8]. The n-3 LC-PUFA, EPA and DHA, have been shown to regulate SREBP-1 
expression through both transcriptional and posttranslational mechanisms and that 
suppression of SREBP-1 transcription was dependent upon LXRα [9].  
      In recent years, the regulation of lipid and fatty acid metabolism in fish has received 
increasing attention [10]. A single LXR cDNA was isolated and characterised from Atlantic 
salmon showing that it was similar to mammalian LXRα [11]. The LC-PUFA synthesis 
pathway has been extensively studied and salmon were shown to have multiple Fad proteins 
with the necessary Δ6 and Δ5 activities [12-14], and Elovls, including Elovl5 and Elovl2 [15] 
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for biosynthesis of EPA and DHA. Several studies have shown that salmon Fad and Elovl 
genes are regulated at the transcriptional level after reduced dietary LC-PUFA resulting in 
increased expression and correspondingly increased LC-PUFA biosynthesis [15-18]. 
Furthermore, gene promoter studies have implicated SREBPs as important transcriptional 
regulators of salmon Δ6 Fad [18]. However, there is very little information regarding SREBF 
genes and their regulatory functions and controls in fish. Molecular studies of SREBPs and 
other lipid homeostatic regulatory systems in fish have been constrained by a lack of tractable 
cellular systems, most work having been conducted on tissues from fish at various 
developmental stages and under different dietary regimes. 
      As described above, fish, as suppliers of “omega-3”, have obvious relevance to human 
health. However, with the decline in commercial fisheries [19], an increasing proportion of 
fish, 50 % globally, are now farmed [20] and so research into lipid and fatty acid metabolism 
in fish is critical with two issues paramount. In Europe aquaculture is largely focussed on 
carnivorous species and so diets have traditionally been based on fishmeal and fish oil, which 
themselves are derived from wild fisheries that have reached their sustainable limit as well as 
being an environmentally and ecologically unsound practice  [21]. Therefore, to produce the 
fish required for the burgeoning human population, sustainable alternatives to marine fish oil 
are required. Vegetable oils are the prime candidates but they are devoid of LC-PUFA, a 
problem compounded by the fact that endogenous biosynthesis of LC-PUFA from C18 PUFA, 
as supplied by vegetable oils, is inefficient in vertebrates, including fish [22-23]. As well as 
supplying essential fatty acids, dietary lipid also supplies energy and the more energy 
supplied by dietary lipid, the less dietary protein will be used for energy, and so more protein 
can be “spared” for synthesis of new tissue/flesh [24]. Therefore, recent dietary formulations 
have shown an upward trend in dietary lipid content, particularly in the case of Atlantic 
salmon [25]. Although the use of “high-energy” feeds has successfully increased weight 
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gains, several studies have shown that a potential and, perhaps, detrimental effect of high fat 
diets is the deposition of excess lipid in tissues [25]. 
      A greater understanding of the molecular basis of lipid and fatty acid homeostasis in fish 
will enable efficient and effective use of sustainable dietary oils while maintaining the 
nutritional quality of farmed fish. The aims of the present study were to identify SREBP 
genes in Atlantic salmon and to characterise their response, and the response of other 
potential target and regulatory genes, to cholesterol and LC-PUFA in the established salmon 
cell line, SHK-1. The results show clear patterns of response indicating interaction between 
SREBPs and LXR in the regulation of lipid and fatty acid metabolism in salmon cells. 
However, the data also revealed that regulation and control of LC-PUFA biosynthesis in 
salmon may differ from that in mammals as it appeared that fatty acyl elongase Elovl5 may 
be a direct target gene of liver X receptor whereas, in mammals, Elovl5 is an indirect target 
of LXR, responding to LXR-dependent increases in SREBP-1. 
 
Materials and methods 
 
Fish 
Atlantic salmon (Salmo salar) for the provision of RNA for cDNA cloning and tissues for 
determining gene expression were obtained from a study described in detail previously [26]. 
Briefly, tissue samples were obtained from four 2-year old fish maintained in sea pens (Loch 
Duich, Lochalsh, Scotland) and fed a standard fish oil diet containing 32 % lipid (Skretting 
ARC, Stavanger, Norway) and formulated to satisfy the nutritional requirements of salmonid 
fish [27]. All tissue samples were immediately frozen in liquid nitrogen and subsequently 
stored at -70 °C. 
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Cell culture and treatments 
The Atlantic salmon established cell line, SHK-1, originated from salmon head kidney tissue 
and are likely leucocyte-derived, showing both macrophage- or dentritic-like phenotype 
[28,29]. The cells were routinely cultured in 75 cm2 flasks (Nunc, Denmark) at 25 ˚C in 
Leibovitz's L-15 with GlutaMAX™-l supplemented with L-glutamine (4 mM final conc.), 
penicillin G (50 U/ml), streptomycin (50 µg/ml), 0.08 % mercaptoethanol, and 5 % foetal 
bovine serum (FBS) (normal medium). All components were from Gibco®/Invitrogen, UK 
with the exception of FBS that was from Biosera, UK. Lipid-free medium was as above 
except the serum supplement was 5 % delipidated (charcoal-treated) FBS 
(Gibco®/Invitrogen, UK). For sub-culturing, the cell monolayer was washed twice with 
phosphate buffer saline (PBS) without CaCl2 or MgCl2 (Gibco®/Invitrogen, UK), cells 
detached by incubation with 0.05 % trypsin/ 0.02 % EDTA, re-suspended in normal medium 
and redistributed in daughter flasks at a ratio of 1:3.  
For experiments, viable cells were counted after harvesting using 0.4 % Trypan Blue 
(Sigma, UK), a Neubauer haemocytometer and inverted microscope (IMT-2, Olympus), and 
seeded in 6-well plates (Nunc, Denmark) at a density of 0.4×106 cells/well in a volume of 3 
ml. Cells were approximately 70% confluent after 48 h growth (24 h in normal media 
followed by 24 h in delipidated medium), after which medium was aspirated, cells washed 
twice with PBS and the experimental conditions applied. Cells were exposed to either 
cholesterol, EPA or DHA in ethanol at concentrations of 20 µM for each, with parallel 
control cultures receiving ethanol carrier alone. Cells were harvested at 24 and 72 h after 
treatment. The medium was removed, cells washed twice with 1 ml of PBS per well, the 
monolayer scraped from the well in 0.5 ml of PBS and transferred to a microfuge tube before 
RNA extraction as below. 
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In addition, lipid contents of cells at 0 h and 72 h (control, cholesterol, EPA and 
DHA) were determined using 6 wells per treatment/time point (triplicate samples of two 
pooled wells). The cell layers were washed with PBS, scraped in 2 ml of PBS per well and 
the content of two wells (4 ml) transferred to a glass test tube and centrifuged to pellet the 
cells. The PBS was removed, 5 ml chloroform/methanol (as above) added and the cells 
extracted by mixing with a glass Pasteur pipette. One ml of 0.88 % KCl were then added and 
the extracts thoroughly mixed by vortexing. The tubes were centrifuged and the lower 
organic layers removed to clean tubes and solvent evaporated under a stream of nitrogen. 
Lipid extracts were desiccated for 2 h and total lipid contents determined gravimetrically.  
 
RNA extraction and cDNA synthesis 
Cell samples were centrifuged at 3000 g for 10 min, the PBS removed, 0.5 ml of TRI Reagent 
was added and total RNA extracted following the manufacturer’s instructions (Ambion, UK). 
Three replicates wells were taken per treatment and time point. Total RNA was extracted 
from salmon tissues by homogenisation in TRI Reagent® RNA extraction buffer following 
the manufacture instructions. Quantity and quality of isolated RNA was determined by 
spectrophotometry with an ND-1000 Nanodrop (Labtech Int., East Sussex, UK) and 
electrophoresis using 1 µg of total RNA in a 1 % agarose gel. Prior to cDNA synthesis, 1 µg 
of total RNA was incubated at 70 °C for 5 min followed by 2 min on ice. For cDNA 
synthesis, 1µL of a 3:1 mix of random hexamers (400 ng/µL)/oligo dT (500 ng/µL), 2 µL 
dNTP (5 mM), 1µL of reverse transcriptase, and 1µL of RT enhancer (DNAse) were mixed 
with kit buffer in a final volume of 20 µL (Verso™ cDNA kit, ABgene, UK), and incubated 
at 42 °C for 60 min, followed by 95 °C for 2 min to inactivate the enzymes. The resulting 
cDNA was diluted 10-fold with milliQ water. 
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Isolation of SREBP-1 and SREBP-2 cDNAs   
The Atlantic salmon gene index (http://compbio.dfci.harvard.edu/tgi/) was interrogated using 
human SREBP-1 (GenBank ID: NM_001005291) and SREBP-2 (GenBank ID: NM_004599) 
and homologous transcribed contig sequences TC148424 and TC166313 were identified for 
SREBP-1 and SREBP-2, respectively. The SREBP-1 and SREBP-2 transcribed contigs each 
consisted of the 3’ end of the cDNAs including the stop codon and 2.0 and 1.4 kb of 3’ 
untranslated sequence, respectively. Rapid Amplification of cDNA Ends (RACE)-PCR was 
performed and RACE cDNAs generated from 1 µg of salmon liver total RNA as described in 
the manual using the SMART™ RACE kit (Clontech, USA). The 5’ RACE amplicons were 
generated by two rounds of PCR using SREBP-1 (Srebp1 5’R1 and Srebp1 5’R2) or SREBP-
2 (Srebp2 5’R1 and Srebp2 5’R2) gene-specific degenerate primers. Primers were designed 
by selecting conserved areas, from alignments of DNA sequences of zebrafish (Danio rerio) 
(Ensembl transcript ID: SREBP1 ENSDART00000092665, SREBP2 
ENSDART00000092690), pufferfish (Tetraodon negroviridis) (Ensembl transcript ID: 
SREBP1 ENSTNIT00000015119, SREBP2 ENSTNIT00000013959) and stickleback 
(Gasterosteus aculeatus) (Ensembl transcript ID: SREBP-1 ENSGACT00000015997, 
SREBP-2 ENSGACT00000009636). The final full-length PCR products were obtained by 
two rounds of PCR using nested primers designed to amplify end to end full length cDNAs 
(Srebp1Full-F1, Srebp1Full-R1 and Srebp1Full-F2, Srebp1Full-R2 for SREBP-1; 
Srebp2Full-F1, Srebp2Full-R1 and Srebp2Full-F2, Srebp2Full-R2 for SREBP-2). All PCRs 
were run at an annealing temperature of 60 °C and the extension time was 1 min/Kb of 
predicted PCR product, and 3 min were applied for unpredictable RACE PCR products. All 
primers were designed using PrimerSelect Ver. 6.1 program (DNASTAR, www.dnastar.com) 
(Table 1). 
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Sequence analysis 
Sequencing was performed using a Beckman 8800 autosequencer, and Lasergene SEQman 
software (DNASTAR) used to edit and assemble DNA sequences. As SREBP sequence 
annotation was incomplete in fish species with sequenced genomes, and in order to predict 
the full-length polypeptide sequences, salmon SREBP cDNA sequences were used to 
interrogate pufferfish, stickleback and zebrafish genomes (www.Ensembl.org) using TBlastX. 
Regions of chromosomal DNA sequences containing homologous sequences were processed 
with GeneWise2 (www.ebi.ac.uk) using the salmon sequence as a key to generate predicted 
polypeptide sequences. Multiple alignments of deduced protein sequences were generated by 
ClustalW [30], and the neighbour joining method [31] and MEGA version 4 [32] used to 
deduce and bootstrap phylogenetic trees. 
 
Quantitative PCR (qPCR) 
Oligonucleotide primers for target genes (Table 1), SREBP-1, SREBP-2, LXR, ∆5Fad and 
∆6Fad_a, Elovl2 and Elovl5a elongases, fatty acid synthase (FAS), acyl-CoA oxidase 
(ACOX), 7-dehydrocholesterol reductase (DHCR7), 3-hydroxy-3-methylglutaryl-coenzyme 
A reductase (HMG-CoAR), mevalonate kinase (MVK), isopentenyl-diphosphate delta-
isomerase 1 (IDI1) and reference genes (β-actin, EF1α, Gapdh and α-tubulin) were used at 
0.3 µM with one-fortieth of the cDNA synthesis reaction (5 µl of a 1:10 dilution) and 10 µl of 
SYBR-green qPCR mix (ABgene, UK) in a total volume of 20 µl. Reactions were run in a 
Techne Quantica thermocycler at annealing temperatures of 58 ºC for LXR and IDI1, 60 ºC 
for Δ5Fad, Δ6Fad, Elovl2, Elovl5a, ACOX, FAS, HMG-CoAR and DHCR7, 61 ºC for MVK, 
β-actin, EF1α, Gapdh, α-tubulin and 18s, and 63 ºC for SREBP-1 and SREBP-2 to give PCR 
products of 210, 140, 191, 180, 145, 141, 230, 159, 224, 183, 196, 120, 175, 204, 124, 189, 
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151 and 147 bp, respectively. Each qPCR product was sequenced to confirm identity and 
each was 100 % identical to its predicted sequence. Quantification was achieved by a parallel 
set of reactions containing standards consisting of serial dilution of spectrophotometrically 
determined, linearised plasmid containing the above mentioned cDNA sequences. 
Normalisation of copy number across biological samples was achieved by using a 
normalisation factor (NF), based on the geometric mean expression of two reference genes 
(β-actin and EF1α) determined using geNorm software [33]. For comparison of expression 
levels of target genes across diverse tissues, the target gene copy number was normalized to 
18s ribosomal RNA copy number.  
 
Statistical analysis 
All data are presented as means ± SD (n = 3 for cell studies or 4 for tissue expression). 
Statistical analysis was performed using the Minitab v.15.1 statistical software package 
(Minitab Inc., USA). Data were assessed for normality with the Kolmogorov-Smirnov test 
and for homogeneity of variances by Bartlett’s test and examination of residual plots and, 
where necessary, data were transformed to improve normality. Data were analysed by full 
factorial two-way analysis of variance (ANOVA) using time and treatment as the fixed 
factors, with post hoc multiple comparisons applied using Tukey’s test [34]. A significance of 
p < 0.05 was applied to all statistical tests performed.  
 
Results 
Atlantic salmon SREBP-1 and SREBP-2 isolation 
Several rounds of RACE cDNA synthesis using primers designed to salmon SREBP-like 
sequences yielded multiple amplicons that, when assembled, predicted full-length cDNA 
sequences coding for two SREBP-like proteins. The existence of these as complete expressed 
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transcripts was confirmed by “end to end” RT-PCR which generated two distinct cDNAs, 
each of which contained an entire open reading frame for a protein with high identity to 
mammalian SREBPs.  
Alignment and phylogenetic analysis of the salmon proteins with other previously 
characterised SREBPs from invertebrate and vertebrate species including SREBPs predicted 
by alignment to fish genome sequences, show that all vertebrates possess two SREBP 
proteins that robustly cluster in two different clades containing mammalian SREBP-1 and 
SREBP-2 sequences respectively, and that homologous genes for each of the SREBP forms 
exist in other fish species including salmon (Fig.1 and supplementary Figure). In addition, the 
deduced protein sequences showed that the salmon SREBP-1 sequence was more similar to 
the mammalian SREBP-1a isoform (Fig. 2).  Thus, taking all of the sequence evidence, 
salmon SREBP-1 cDNA contained an open reading frame of 3516 bp (1172 amino acids) and 
a 3’ and 5’ untranslated regions of 174 and 838 bp respectively (GenBank accession number 
HM561860). The deduced salmon SREBP-1 protein sequence displayed 54 % and 70 % 
identity with human SREBP-1a and zebrafish SREBP-1 sequences. The full length cDNA of 
salmon SREBP-2 was 4884 bp which contained an open reading frame of 3243 bp (1081 
amino acids) and a 5’ and 3’ untranslated regions of 233 and 1408 bp respectively (GenBank 
accession number HM561861). The deduced salmon SREBP-2 protein sequence displayed 49 
% and 70 % identity with human and zebrafish SREBP-2 sequences. 
 
Tissue distribution of salmon SREBP-1 and SREBP-2 mRNAs 
Expression profiles of salmon SREBP-1 and SREBP-2 were very similar in each of the tissue 
tested with highest levels of expression in intestine (pyloric caeca), then brain > gill > liver > 
heart, spleen, kidney, red and white muscle (Fig. 3).  
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Response of SHK-1 cells exposed to cholesterol, EPA and DHA 
Transcriptional responses of SHK-1 cells are presented in Figs. 4-6. We manipulated the lipid 
content of SHK-1 cells by growing cells over an extended period in lipid-free medium, and 
by treatment with excess cholesterol, EPA or DHA. After 72 h in lipid-free medium, cells 
were still sub-confluent but showed decreased lipid content (Table 2). There was a clear 
effect of time on SREBP-1, Δ5Fad, Δ6Fad, MVK and FAS. Message levels of these genes 
increased over the 72 h period. Supplementation of EPA, DHA or cholesterol prevented the 
increase in mRNA expression of Δ6Fad and FAS, showed a similar though not significant 
effect on Δ5Fad and MVK, and highly decreased expression of SREBP-1. There was also a 
smaller increase in expression of SREBP-2 after 72 h, which was not affected by DHA or 
EPA. Treatment with DHA also caused an increase in HMG-CoAR mRNA after 72 h. 
Supplemental cholesterol caused a dramatic increase in LXR mRNA expression, up to 
18-fold at 72 h after treatment. An increase in the expression of both salmon SREBP-1 and 
SREBP-2 mRNAs was also observed, with the largest effect seen on SREBP-1. The 
increased levels of these transcription factor mRNAs were accompanied by increased 
expression of Elovl5a, ACOX and HMG-CoAR at both the 24 h and 72 h time-points. The 
expression of IDI1 mRNA also increased, but only at 24 h after treatment, whilst no effect on 
DHR7 expression was observed with any treatment. The pattern of expression of Elovl2 
mRNA was different from all other genes. Elovl2 was reduced by DHA after 24 h only, and 
highly decreased 72 h following cholesterol supplementation.  
 
Discussion 
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Lipid and protein pathways dominate intermediary metabolism in carnivorous fish, such as 
Atlantic salmon, as carbohydrate is only a minor nutrient in their diet [25]. However, 
although the regulation of lipid biosynthesis and metabolism in Atlantic salmon is of great 
importance for nutrition and quality of farmed fish and also for understanding key life history 
transitions in wild fish, studies at the molecular level have been hampered by a lack of 
suitable experimentally tractable systems and manipulatable candidate genes. Previous 
studies in mammalian species [6] and in salmon [16,18] have indicated the importance of 
SREBP transcription factors, particularly in relation to the control of lipid and cholesterol 
biosynthesis. One aim of the present study was to identify and compare salmon SREBPs with 
characterised SREBPs from other species. We have synthesised and sequenced two complete 
SREBP cDNAs from Atlantic salmon, which enabled, by homology searching, SREBPs to be 
structurally characterised in other fish species with sequenced genomes. To verify whether 
fish species contain multiple genes for SREBPs, the salmon cDNA sequences were used to 
search for similar sequences in the zebrafish, pufferfish, medaka and stickleback genomes. In 
each species two SREBP genes were identified and in all fish each of these was clearly 
related to SREBP-1 or SREBP-2 from mammals. Thus, teleost fish contain homologues of 
mammalian SREBP-1 and SREBP-2 and these homologues must have arisen from a gene 
duplication preceding the evolutionary divergence of teleosts and mammals, but after the 
vertebrate-invertebrate division, since invertebrates contain only one SREBP gene [35]. Neo-
functionalisation of duplicated SREBP gene isoforms, following the early vertebrate whole 
genome duplication, may have been driven by the necessity to independently regulate fatty 
acid and cholesterol biosynthesis and metabolism [36]. 
      In mammals two major forms of SREBP-1, SREBP-1a and SREBP-1c, are expressed as a 
result of alternative splicing and are differentially expressed across tissues [37]. SREBP-1c is 
highly expressed in liver whilst in other tissues, particularly lipogenic tissues and in cultured 
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human cells, SREBP-1a predominates. SREBP-2 is more generally expressed. We found no 
evidence of alternatively spliced mRNAs in salmon, although this cannot at present be 
excluded since SREBP cDNAs were only synthesised from liver RNA. Furthermore, tissue 
expression profiling showed that both salmon SREBP genes were expressed at the same level 
in each of the tissues examined. However, the qPCR primers for SREBP-1 were designed in 
an area that corresponds to an identical region in both mammalian SREBP-1a and SREBP-1c 
and thus the expression patterns of SREBP-1 in the present study represent the expression of 
either transcript. 
      Alignments and phylogenetic analysis of the deduced amino acid sequence of SREBP 
proteins derived from genome sequences of other fish species, bird, amphibian and human 
and also from insect and worms show areas of very strong sequence conservation 
(supplementary Fig. and Fig. 1). The features which characterize mammalian SREBPs such 
as the transcription activation domain, proline/serine-rich domain, DNA binding domain 
including the tyrosine that characterises SREBP DNA binging motifs (bHLH-LZ) domains, 
the serine/proline/glycine-rich domain, the two transmembrane domains and the regulatory 
carboxyl-terminus domain are conserved in fish SREBPs [38]. A site cleaved by caspase 3 
and 7 is also conserved in both salmon SREBPs [39] (supplementary Fig.1).  
       Mammalian SREBP-1 and SREBP-2 regulate distinct, but overlapping sets of target 
genes. SREBP-1 predominantly acts to increase the expression of genes involved in fatty acid 
synthesis, including FAS, Fad and Elovl genes [7]. SREBP-2 predominantly regulates genes 
of cholesterol biosynthesis, although there is limited reciprocal regulation of the two 
pathways by each SREBP protein. Furthermore, SREBP-1 activity is increased by depletion 
of LC-PUFA, while SREBP-2 is increased by depletion of cholesterol [6].  
Previous studies have indicated the role of SREBPs in regulating genes such as thosse 
of cholesterol and LC-PUFA biosynthsis involved in the adaptation to vegetable oil-based 
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diets in salmon liver [10, 13-17]. In order to study this process in more detail we searched for 
a cellular model for salmon lipid homeostasis. Due to the scarcity of salmon cell lines and the 
absence of a hepatocyte-like model, we targeted the macrophage-like SHK-1 cell line 
[28,29]. This was based on the rationale that the critical transcriptional regulators of 
macrophage lipid homeostasis are the same as those in liver, and they regulate similar target 
genes [40]. In addition, macrophages have been shown to reflect diet-induced physiological 
responses and exhibit associated gene expression changes similar to liver [41]. Therefore, in 
SHK-1 cells we have measured mRNA expression of genes of fatty acid and LC-PUFA 
biosynthesis, cholesterol biosynthesis and peroxisomal β-oxidation as well as levels of 
SREBP-1, SREBP-2 and LXR mRNAs. In response to depletion of lipid (i.e. cholesterol and 
fatty acids), there were increases in expression of cholesterol biosynthetic enzymes IDI1 and 
MVK. Treatment with cholesterol or with EPA/DHA had no further effect. The expression of 
a second group of genes also increased after lipid depletion but this was negated by 
cholesterol or by EPA/DHA. This group contained genes belonging to fatty acid biosynthetic 
pathways and included FAS, Δ6Fad and Δ5Fad. The expression of a third group of genes was 
increased by cholesterol treatment but was not affected by lipid depletion or by EPA/DHA 
and included Elovl5, ACOX and, surprisingly, HMG-CoAR. Expression of LXR was also 
increased by cholesterol and not affected by lipid depletion or by EPA/DHA. Thus, based on 
the similarities of expression profiles, it is possible that the genes of Elovl5, ACOX and 
HMG-CoAR are direct targets of LXR. For ACOX, this conclusion is supported by the 
observation that LXR agonists cause increases in ACOX and in peroxisomal lipid oxidation 
in mice [42]. However, salmon Elovl5 may be regulated differently from mammalian Elovl5, 
which is an indirect target of LXR, responding to LXR-dependent increases in SREBP-1 
[43]. Similarly the response of HMG-CoAR is surprising since in mammalian systems LXR 
may in fact negatively regulate this gene, possibly through a post-transcriptional mechanism 
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[44]. HMG-CoAR catalyses an early step in cholesterol and terpenoid biosynthesis and in 
mammals is primarily regulated by post-translational and proteolytic mechanisms, although it 
is also a SREBP target [7]. A previous study on salmon liver also showed HMG-CoAR to 
behave contrary to expectation, in that there was no increase in mRNA expression of this 
gene in response to low dietary cholesterol, despite increases in other genes of cholesterol 
biosynthesis [16]. Clearly these results indicate that HMG-CoA is likely to be regulated 
differently in salmon compared to mammals. 
      All other measured genes that responded to lipid depletion are likely to be targets of 
SREBP transcription factors. Since these fell into two groups, that is those whose expression 
was unaffected by cholesterol or EPA/DHA and those whose expression was decreased by 
cholesterol or EPA/DHA, it may be that these groups represent preferential targets of 
SREBP-1 and SREBP-2. Notably, although expression levels of SREBP-1 and SREBP-2 
were both increased by supplementary cholesterol, only SREBP-1 was reduced after 
EPA/DHA treatment, indicating that FAS, Δ6Fad and Δ5Fad, also reduced after EPA/DHA 
treatment, are more likely to be SREBP-1 targets. Similar to SHK-1 cells, the expression of 
both rodent and human Δ5 and Δ6 desaturase genes is higher under a low fat diet [45,46]. 
Furthermore the human Δ6 desaturase gene contains a SREBP-1 response element which 
mediates LC-PUFA suppression of expression [47] and this element is conserved in the 
salmon gene [18]. However, it will be necessary to more fully characterise the salmon LXR 
with regard to its activation by synthetic ligands in order to fully distinguish LXR and 
SREBP regulation. For example, in mammals the FAS gene is a direct target of both LXR 
and SREBP-1 and the promoter recognition sequences for these transcription are conserved in 
birds [48] Thus, in salmon, either the FAS gene is not a target of LXR, or LXR-effects are 
masked by SREBP-1, which may be also be the case for the other genes sharing SREBP 
expression profiles in SHK-1 cells. 
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      Although SREBP mRNA was increased in SHK-1 cells after supplementary cholesterol, 
this was not reflected in increases in putative target gene expression after cholesterol 
treatment. Proteolytic activation of SREBPs occurs after sensing lipid levels and so it is likely 
that, although mRNA and perhaps SREBP protein was increased following cholesterol 
treatment, this was not reflected in increased SREBP proteolytic activation pathways. These 
increases in SREBP mRNA may be secondary to increases in LXR. The mammalian SREBP-
1 gene is regulated by LXRα that is activated by binding oxysterols (cholesterol metabolites) 
arising from increased intracellular cholesterol [49,50]. The LXRs play a critical role in 
reverse cholesterol transport by responding to elevated oxysterol concentrations through 
regulation of cholesterol 7α-hydroxylase which catalyses the rate-limiting step in bile acid 
synthesis, and by up-regulating ATP-binding cassette transporters, ABCG5 and ABCG8, 
which pump free cholesterol from hepatocytes into bile or from macrophages to the 
circulation [51]. Thus, one explanation for the increase in SREBP mRNA in SHK-1 cells 
after supplementary cholesterol is that, as in mammals, consequent increases in cholesterol 
metabolites upregulate LXR, which in turn activates SREBP genes. 
      The elongase Elovl2 was not consistently changed by any treatment, and thus could not 
be included in any of the groups of genes to which we were able to infer a possible regulatory 
mechanism. However, expression of Elovl2 mRNA was drastically reduced following 
cholesterol treatment at the highest lipid depletion point. Since EPA/DHA biosynthesis 
requires Elovl5, Elovl2 and Fad genes [12,15], and each of these genes is regulated 
differently in response to cellular lipid status, the factors that determine levels of LC-PUFA 
synthesis in salmon are likely to be complex. 
      In conclusion, these results indicate that the established cell line is a useful system in 
which to further study the molecular basis of lipid homeostasis in Atlantic salmon. The 
present study has revealed that SREBP and LXR interact in the regulation of range of genes 
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key to lipid homeostasis. In some cases the interactions appear generally similar to those 
being elucidated in mammalian systems. However, the present study has revealed that Elovl5, 
an important enzyme for the conversion of the C18 PUFA, 18:3n-3, to LC-PUFA, EPA and 
DHA, appears to be regulated differently in salmon compared to mammals, possibly being a 
direct target for LXR, rather than being regulated primarily by SREBP-1, albeit in an LXR-
dependent pathway. This finding requires confirmation by direct promoter analyses involving 
the identification of functional binding sites of the salmon elovl5 gene, similar to those 
studies recently performed on fish fad genes [18]. The regulation of endogenous LC-PUFA 
biosynthesis pathway in salmon is particularly important considering the critical role of n-3 
LC-PUFA for human health, the role of oily fish such as salmon for provision of n-3 LC-
PUFA in the human diet, and the changes to salmon feed driven by environmental, ecological 
and sustainability issues. 
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Figure captions 
 
Fig.1. Phylogenetic tree comparing the deduced AA sequences of salmon SREBPs with 
SREBP proteins from fish and other organisms. The tree was constructed using the neighbor 
joining method with MEGA4 [31,32]. The horizontal branch length is proportional to AA 
substitution rate per site. The numbers represent the frequencies with which the tree topology 
presented was replicated after 1000 iterations. 
 
Fig.2. SREBPs protein structure. A: organization of SREBPs trans membrane precursor 
protein and nuclear, mature transcription factor. B: Amino terminus of SREBP-1 proteins 
highlighting the higher similarity of fish SREBP-1 to human SREBP-1a.  [Adapted from 38]. 
 
Fig.3. Tissue expression profile of SREBP-1 and SREBP-2. Gene expression is represented 
as copy number relative to 18s RNA and values are means ± S.D. (n = 4). Bars bearing 
different letters are significantly different (p < 0.05; ANOVA, Tukey’s test). PC, pyloric 
caeca; RM, red muscle; WM, white muscle. 
 
Fig.4.  Expression of liver X receptor (LXR), sterol regulatory element binding protein-1 and 
-2 (SREBP-1, SREBP-2) in SHK-1 cells exposed to 20 µM cholesterol, eicosapentaenoic 
acid (EPA), docosahexaenoic acid (DHA) or carrier alone (control). Expression is 
represented in copy numbers. Normalization was performed by geNorm using a 
normalization factor (NF) based on the geometric mean of β-actin and elongation factor-1α 
reference genes. Values are means ± S.D. (n = 3). Bars bearing different letters are 
significantly different (P < 0.05; ANOVA, Tukey’s test).  
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Fig. 5. Expression of acyl-coenzyme A oxidase (ACOX), fatty acyl elongases 2 and 5a 
(Elovl2, Elovl5a), Δ5 and Δ6 fatty acyl desaturases (Δ5Fad, Δ6_a Fad) and fatty acid 
synthase (FAS) in SHK-1 cells exposed to 20 µM cholesterol, eicosapentaenoic acid (EPA), 
docosahexaenoic acid (DHA) or carrier alone (control). Data, normalisation and statistics are 
all as described in legend to Fig. 4. 
 
Fig. 6. Expression of 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoA R), 
mevalonate kinase (MVK), isopentenyl-diphosphate delta isomerase 1 (IDI1) and 7-
dehydrocholesterol reductase (DHCR7) in SHK-1 cells exposed to 20 µM cholesterol, 
eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) or carrier alone (control). Data, 
normalisation and statistics are all as described in legend to Fig. 4. 
 
 
 
 
 
 
 
 27 
 
 
 28 
 
 
 29 
Fig.1. 
 
 30 
 
Fig.2. 
 
 31 
Fig.3. 
 
 32 
Fig.4. 
 
 33 
Fig.5. 
 
 
 34 
Fig.6 
 
 
 35 
 
